English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Often misdiagnosed as liver cancer at first, Alveolar hydatid disease or hepatic alveolar echinococcosis, is an uncommon but extremely dangerous form of echinococcosis caused by the larvae of the species Echinococcus multilocularis, affecting liver, later diffusing to the lung and brain and typically fatal if left untreated. Drug therapy continues to be crucial and indispensable for patients with end-stage echinococcosis, despite the fact that surgery is still the preferred method of treatment for the disease. The purpose of this chapter is to provide an overview of how FDA-approved medications and nano drug delivery technologies work in harmony to treat advanced hepatic alveolar echinococcosis.

Perspective Chapter: Prospects for Pharmacological Therapy of Hepatic Alveolar Echinococcosis